Reporting the Impact of Pelvicalyceal System (PCS) Anatomy on Clinical Outcomes in Retrograde Intrarenal Surgery (RIRS) Studies: Can We Do Better? - Methodological Review from the Section of EAU Endourology

报告肾盂肾盏系统(PCS)解剖结构对逆行性肾内手术(RIRS)临床结局的影响:我们能否做得更好?——欧洲泌尿外科协会(EAU)内镜泌尿外科分会的方法学综述

阅读:1

Abstract

To analyze available randomized clinical trials (RCTs) comparing retrograde intrarenal surgery (RIRS) with other modalities for urinary stone treatment to determine the extent of comparing the pelvicalyceal system (PCS) anatomy between patients. In December 2024, a search was conducted in databases and was limited to publications that describe comparisons of experimental and control groups in the context of RIRS for stones only in the kidney (PCS). Only RCTs comparing RIRS with other modalities without publication date restriction were included due to their highest level of evidence in the hierarchy of primary research. The parameters used in the selected studies were analyzed to compare the differences between the groups, focusing on PCS anatomy. The final analysis included 27 publications from 2421 articles. The presence and/or degree of hydronephrosis were analyzed in 8 studies. Direct morphometric measurements were compared in 4 studies and were focused on the lower pole only, namely the infundibulopelvic angle, infundibular length, and infundibular width. Features such as the position of the renal pelvis in relation to the kidney parenchyma (intrarenal, extrarenal), number and orientation of calyces, as well as the existing PCS classifications were not compared or used. This review shows gaps in the literature while assessing and reporting on PCS anatomy in studies with RIRS. Unless studies mention these anatomical factors without excluding certain groups of patients, it is difficult to compare outcomes between modalities and in between studies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。